Add-on Acquisition • Medical Products

Endologix Acquires PQ Bypass

On April 13, 2021, Endologix acquired medical products company PQ Bypass

Acquisition Context
  • This is Endologix’s 2nd transaction in the Medical Products sector.
  • This is Endologix’s 2nd transaction in the United States.
  • This is Endologix’s 2nd transaction in California.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date April 13, 2021
Target PQ Bypass
Sector Medical Products
Buyer(s) Endologix
Deal Type Add-on Acquisition

Target Company

PQ Bypass

Milpitas, California, United States
PQ Bypass is a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD). PQ Bypass devices are built upon nearly a decade of research and patented technological advancement. PQ Bypass was founded in 2009 and is based in Milpitas, California.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Endologix

Irvine, California, United States

Category Company
Founded 1992
Sector Medical Products
Revenue 156M USD (2018)
DESCRIPTION

Endologix is a medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. Endologix was founded in 1992 and is based in Irvine, California.


Deal Context for Buyer #
Overall 2 of 2
Sector: Medical Products 2 of 2
Type: Add-on Acquisition 2 of 2
State: California 2 of 2
Country: United States 2 of 2
Year: 2021 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-27 Nellix

Palo Alto, California, United States

Nellix, Inc. develops novel solutions for vascular disease

Buy $15M